Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01548534 | A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer(DHALYA) | terminated | Phase 3 | 65 | University Hospital, ToursOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT00990977 | Mindfulness and Cancer Mamma - Clinical Trial MBSR Among Women Operated for Breast Cancer(MICA) | completed | Phase 2 / Phase 3 | 336 | Danish Cancer SocietyOTHER | 1 | Jun 30, 2015 |
| clinicaltrials |
| NCT00581113 | Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases | terminated | Phase 3 | 8 | Virginia Commonwealth UniversityOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT02449954 | Effect of Morphine, Tramadol, and Ketorolac on Postoperative Stress and Immune Responses | unknown | Phase 2 / Phase 3 | 60 | Assiut UniversityOTHER | 0 | May 21, 2015 | clinicaltrials |
| NCT02450058 | Adjuvant FEC Versus EP in Breast Cancer (MIG5)(MIG5) | completed | Phase 3 | 1,055 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT00424606 | Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients | completed | Phase 3 | 658 | Hellenic Oncology Research GroupOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT01519700 | Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim(PIONEER) | completed | Phase 3 | 218 | SandozINDUSTRY | 6 | May 6, 2015 | clinicaltrials |
| NCT00201851 | Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | completed | Phase 3 | 740 | International Breast Cancer Research FoundationOTHER | 3 | Apr 29, 2015 | clinicaltrials |
| NCT01300351 | Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women | completed | Phase 3 | 249 | AstraZenecaINDUSTRY | 1 | Apr 24, 2015 | clinicaltrials |
| NCT02408107 | A Home-based Physical Activity Intervention in Breast Cancer Survivors(PHAB) | completed | Phase 3 | 80 | Dudley Group NHS Foundation TrustOTHER | 0 | Apr 14, 2015 | clinicaltrials |
| NCT00542542 | Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery | completed | Phase 3 | 89 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2015 | clinicaltrials |
| NCT01287624 | Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)(TNBC) | completed | Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT00512993 | Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy(NATAN) | completed | Phase 3 | 654 | GBG Forschungs GmbHOTHER | 2 | Mar 5, 2015 | clinicaltrials |
| NCT00615602 | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | completed | Phase 3 | 489 | Hellenic Oncology Research GroupOTHER | 1 | Mar 4, 2015 | clinicaltrials |
| NCT00929240 | A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 3 | 287 | Hoffmann-La RocheINDUSTRY | 11 | Mar 3, 2015 | clinicaltrials |
| NCT00065325 | The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer(EFECT) | completed | Phase 3 | 694 | AstraZenecaINDUSTRY | 15 | Feb 24, 2015 | clinicaltrials |
| NCT00053911 | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | terminated | Phase 3 | — | UNICANCEROTHER | 1 | Dec 16, 2014 | clinicaltrials |
| NCT02314806 | Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla | completed | Phase 3 | 51 | Hospital General Universitario ElcheOTHER | 0 | Dec 11, 2014 | clinicaltrials |
| NCT00983684 | Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer(TARGIT) | completed | Phase 3 | 3,451 | University College, LondonOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT00459771 | Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity | completed | Phase 3 | 210 | The Netherlands Cancer InstituteOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT02295033 | Randomized Boost Versus no Boost Irradiation of Early Breast Cancer | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Nov 19, 2014 | clinicaltrials |
| NCT02292407 | Prospective Pilot Study ANDPrecise(ANDPrecise) | unknown | Phase 3 | 20 | The Netherlands Cancer InstituteOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01067976 | Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI | completed | Phase 3 | 446 | BayerINDUSTRY | 9 | Nov 11, 2014 | clinicaltrials |
| NCT01104584 | Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)(GEMMA 2) | completed | Phase 3 | 460 | BayerINDUSTRY | 9 | Nov 11, 2014 | clinicaltrials |
| NCT01998906 | A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer | completed | Phase 3 | 330 | Hoffmann-La RocheINDUSTRY | 6 | Oct 28, 2014 | clinicaltrials |
| NCT00448279 | THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 58 | Hoffmann-La RocheINDUSTRY | 1 | Oct 24, 2014 | clinicaltrials |
| NCT00082095 | To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older | terminated | Phase 3 | 62 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 1 | Oct 9, 2014 | clinicaltrials |
| NCT02249208 | Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.(SENTINAC-01) | unknown | Phase 3 | 150 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT00320710 | Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer | completed | Phase 3 | 416 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00925548 | STRIDE - STimulating Immune Response In aDvanced brEast Cancer(STRIDE) | terminated | Phase 3 | 16 | EMD SeronoINDUSTRY | 12 | Jul 24, 2014 | clinicaltrials |
| NCT00196859 | Study in Elderly Patients With Early Breast Cancer (ICE) | completed | Phase 3 | 1,500 | GBG Forschungs GmbHOTHER | 1 | Jul 17, 2014 | clinicaltrials |
| NCT00196872 | A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) | completed | Phase 3 | 3,000 | GBG Forschungs GmbHOTHER | 1 | Jul 17, 2014 | clinicaltrials |
| NCT01185132 | Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy(2009-APBI) | recruiting | Phase 3 | 660 | Rocky Mountain Cancer CentersOTHER | 1 | Jun 26, 2014 | clinicaltrials |
| NCT01402193 | Study of Arimidex and Radiotherapy Sequencing | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00109239 | A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer | completed | Phase 3 | — | Genentech, Inc.INDUSTRY | 0 | Jun 18, 2014 | clinicaltrials |
| NCT00547989 | Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery? | completed | Phase 3 | 46 | Maastricht University Medical CenterOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT02132390 | Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea | unknown | Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Jun 4, 2014 | clinicaltrials |
| NCT01142479 | Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy | completed | Phase 2 / Phase 3 | 60 | Taipei City HospitalOTHER_GOV | 1 | May 29, 2014 | clinicaltrials |
| NCT01985724 | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | completed | Phase 3 | 650 | Hellenic Oncology Research GroupOTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT01355523 | The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients(MELODY) | terminated | Phase 2 / Phase 3 | 54 | Melissa Voigt HansenOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01459003 | Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer(BEAUTY) | completed | Phase 3 | 400 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT00712985 | Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)(CTIBL) | completed | Phase 3 | 18 | Milton S. Hershey Medical CenterOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT00091442 | A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | completed | Phase 3 | 751 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 18 | Apr 21, 2014 | clinicaltrials |
| NCT01559194 | Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk(LEAF) | completed | Phase 3 | 82 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 14, 2014 | clinicaltrials |
| NCT02109068 | Lifestyle, Exercise and Nutrition Study 1(LEAN) | completed | Phase 3 | 100 | Yale UniversityOTHER | 1 | Apr 9, 2014 | clinicaltrials |
| NCT00010322 | Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer | terminated | Phase 3 | — | Intarcia TherapeuticsINDUSTRY | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00096967 | A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | completed | Phase 3 | 100 | Genentech, Inc.INDUSTRY | 0 | Mar 26, 2014 | clinicaltrials |
| NCT00175344 | Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer? | completed | Phase 3 | 96 | University of British ColumbiaOTHER | 1 | Feb 19, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Jul 29, 2015source: clinicaltrials